Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
For example, if a beneficiary initiated GLP-1 therapy in September 2024 with a body mass index (BMI) of 37 and has a BMI of 34 at the time of a July 2026 prior authorization request, the prescribing provider should attest that the beneficiary met the BMI 35 criterion at the time therapy was initiated
Patients will receive oral and written information about the study
The evidence here is nuanced and worth exploring in detail
Minimizing air exposure is a good practice, but a small amount of air introduced during a draw is unlikely to cause significant immediate damage
The resulting injection delivers both compounds subcutaneously in a single weekly dose, eliminating the need for separate administrations
